Tampere University Hospital
Tampere, FI- 33521, Finland
NCT Number: NCT02602912
The main purpose of the study is to assess the feasibility and clinical performance of impedance based tissue identification in various spine structures.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Tampere, FI- 33521, Finland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Injeq Bioimpedance Probe (BIP) Needle is a spinal needle that has bioimpedance measurement capability. It consists of traditional needle cannulae and removable bioimpedance probe which enables the measurement of bioimpedance. The needle is connected to measurement device and tissue identifying algorithm. Bioimpedance is measured during the operation and the algorithm detects when the needle tip is in contact with cerebrospinal fluid.
Time frame: During spinal puncture
Measurement device indicates with a sound and visual feedback when needle reaches cerebrospinal fluid (CSF). Physician verifies the location by removing the needle stylet and testing whether CSF flows from the needle, similarly as in traditional process. Detection is true positive if CSF flows from the needle and false positive if not. Even if the device does not detect the spinal fluid, physician performs the CSF test when needed. Physician marks to the case report form whether the device provided detections during the spinal puncture and were the detections true or false detections.
Injeq Ltd
Industry
INJ-SPINE-01 Identification of Spine Structures by Using BIP-Needles
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04794881
Meningitis, Neonate
Chandigarh, India
View Trial DetailsNCT00405522
Neoplasms, Spinal Puncture
Toronto, Ontario, Canada
View Trial DetailsNCT01157247
Agnosia, Anesthesia
Zagreb, Croatia
View Trial DetailsNCT00775112
Spinal Puncture
Lyon, France
View Trial Details